Latest return on equity
CytomX Therapeutics Return on equity
Direct answer
CytomX Therapeutics's return on equity is -37.75%.
The verified market snapshot reports -37.75%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free CytomX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -37.75%
Explore related company data
View CytomX Therapeutics's market capitalizationView CytomX Therapeutics's price-to-book ratioView CytomX Therapeutics's dividend yieldView CytomX Therapeutics's 52-week price rangeView CytomX Therapeutics's revenue growthView CytomX Therapeutics's profit marginView CytomX Therapeutics's debt-to-equity ratioView all CytomX Therapeutics key metricsReturn to CytomX Therapeutics profile